For research use only. We do not sell to patients.
RET-IN-18
CAS No. : 2759292-94-7
Biological Activity：RET-IN-18 is a pyridone compound. is a potent inhibitor of RET. RET-IN-18 is a potent inhibitor of RET. RET-IN-18 has the potential for the research of diseases related to irritable bowel syndrome (IBS) and other gastrointestinal disorders, as well as cancers, and neurodegenerative diseases (extracted from patent WO2022017524A1, compound 1).
Research Area：Cancer|Neurological Disease
Targets：RET
Related Small Molecules:Zeteletinib;RET-IN-5;GSK3179106;Pyrazoloadenine;trans-Pralsetinib;PF 477736;BT-13;RET-IN-8;AD80;JNJ-38158471;Amuvatinib hydrochloride;RET-IN-11;TRK II-IN-1;RET-IN-10;RET-IN-17;RET-IN-7;RET-IN-13;TG101209;WHI-P180;TAS05567;RET-IN-14;FLT3/ITD-IN-4;Pz-1
Trending products：Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use；
- Structurally and synthetically diverse biologically active compounds；
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.；
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.；
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.；
- Customized order volume ranging from milligrams to kilograms scale；
Structurally and synthetically diverse biologically active compounds；
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.
